140 related articles for article (PubMed ID: 34117845)
1. Clinical implication of xenotropic and polytropic retrovirus receptor 1 in papillary thyroid carcinoma.
Zou H; Xiang C
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Feb; 50(1):90-96. PubMed ID: 34117845
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics analyses proposed xenotropic and polytropic retrovirus receptor 1 as a potential diagnostic and prognostic biomarker and immunotherapeutic target in head and neck squamous cell carcinoma.
Wang L
Auris Nasus Larynx; 2023 Feb; 50(1):134-150. PubMed ID: 35690506
[TBL] [Abstract][Full Text] [Related]
3. The gene expression of GPER1 is low in fresh samples of papillary thyroid carcinoma (PTC), and in silico analysis.
Bertoni APS; Manfroi PA; Tomedi J; Assis-Brasil BM; de Souza Meyer EL; Furlanetto TW
Mol Cell Endocrinol; 2021 Sep; 535():111397. PubMed ID: 34273443
[TBL] [Abstract][Full Text] [Related]
4. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
5. Xenotropic and polytropic retrovirus receptor 1 (XPR1) promotes progression of tongue squamous cell carcinoma (TSCC) via activation of NF-κB signaling.
Chen WC; Li QL; Pan Q; Zhang HY; Fu XY; Yao F; Wang JN; Yang AK
J Exp Clin Cancer Res; 2019 Apr; 38(1):167. PubMed ID: 30995931
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value and Significant Pathway Exploration Associated with TOP2A Involved in Papillary Thyroid Cancer.
Gong MC; Chen WQ; Jin ZQ; Lyu J; Meng LH; Wu HY; Chen FH
Int J Gen Med; 2021; 14():3485-3496. PubMed ID: 34290523
[TBL] [Abstract][Full Text] [Related]
7. A human cell-surface receptor for xenotropic and polytropic murine leukemia viruses: possible role in G protein-coupled signal transduction.
Battini JL; Rasko JE; Miller AD
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1385-90. PubMed ID: 9990033
[TBL] [Abstract][Full Text] [Related]
8. BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis.
Zhang C; Bo C; Guo L; Yu P; Miao S; Gu X
World J Surg Oncol; 2019 Dec; 17(1):221. PubMed ID: 31842912
[TBL] [Abstract][Full Text] [Related]
9. F12 as a reliable diagnostic and prognostic biomarker associated with immune infiltration in papillary thyroid cancer.
Luo JH; Zhang XX; Sun WH
Aging (Albany NY); 2022 Apr; 14(8):3687-3704. PubMed ID: 35483340
[TBL] [Abstract][Full Text] [Related]
10. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis.
Pang R; Yang S
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128
[TBL] [Abstract][Full Text] [Related]
11. Papillary thyroid carcinoma with a high tumor mutation burden has a poor prognosis.
Xie Z; Li X; Lun Y; He Y; Wu S; Wang S; Sun J; He Y; Xin S; Zhang J
Int Immunopharmacol; 2020 Dec; 89(Pt B):107090. PubMed ID: 33091816
[TBL] [Abstract][Full Text] [Related]
12. Identification of biomarkers associated with cervical lymph node metastasis in papillary thyroid carcinoma: Evidence from an integrated bioinformatic analysis.
Zhang Z; Zhao S; Wang K; Shang M; Chen Z; Yang H; Chen Y; Chen B
Clin Hemorheol Microcirc; 2021; 78(2):117-126. PubMed ID: 33554894
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide scanning for CHD1L gene in papillary thyroid carcinoma complicated with type 2 diabetes mellitus.
Kang YY; Li JJ; Sun JX; Wei JX; Ding C; Shi CL; Wu G; Li K; Ma YF; Sun Y; Qiao H
Clin Transl Oncol; 2021 Dec; 23(12):2536-2547. PubMed ID: 34245428
[TBL] [Abstract][Full Text] [Related]
14. Tumor Mutation Burden Predicts Relapse in Papillary Thyroid Carcinoma With Changes in Genes and Immune Microenvironment.
Guo M; Chen Z; Li Y; Li S; Shen F; Gan X; Feng J; Cai W; Liu Q; Xu B
Front Endocrinol (Lausanne); 2021; 12():674616. PubMed ID: 34248843
[TBL] [Abstract][Full Text] [Related]
15. The downregulation of lncRNA EMX2OS might independently predict shorter recurrence-free survival of classical papillary thyroid cancer.
Gu Y; Feng C; Liu T; Zhang B; Yang L
PLoS One; 2018; 13(12):e0209338. PubMed ID: 30576338
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis and glycosylation sensitivity of restrictive XPR1 gammaretrovirus receptors in six mammalian species.
Lu X; Kassner J; Skorski M; Carley S; Shaffer E; Kozak CA
Virology; 2019 Sep; 535():154-161. PubMed ID: 31302509
[TBL] [Abstract][Full Text] [Related]
17. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.
Saiselet M; Gacquer D; Spinette A; Craciun L; Decaussin-Petrucci M; Andry G; Detours V; Maenhaut C
BMC Genomics; 2015 Oct; 16():828. PubMed ID: 26487287
[TBL] [Abstract][Full Text] [Related]
18. Identification of key genes of papillary thyroid carcinoma by integrated bioinformatics analysis.
Xue G; Lin X; Wu JF; Pei D; Wang DM; Zhang J; Zhang WJ
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32766727
[TBL] [Abstract][Full Text] [Related]
19. Correlations of HOTAIR expression with pathological stage, CT characteristics and prognosis of patients with papillary thyroid carcinoma.
Chen X; Jin J; Zheng L; Sheng Y; Sun J
J BUON; 2021; 26(1):259-265. PubMed ID: 33721460
[TBL] [Abstract][Full Text] [Related]
20. Use of different but overlapping determinants in a retrovirus receptor accounts for non-reciprocal interference between xenotropic and polytropic murine leukemia viruses.
Van Hoeven NS; Miller AD
Retrovirology; 2005 Dec; 2():76. PubMed ID: 16354307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]